• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受羟基脲治疗的镰状细胞贫血患儿的皮肤和指甲变化。

Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.

作者信息

O'branski E E, Ware R E, Prose N S, Kinney T R

机构信息

Duke University Pediatric Sickle Cell Program and Division of Hematology/Oncology, Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

J Am Acad Dermatol. 2001 May;44(5):859-61. doi: 10.1067/mjd.2001.113471.

DOI:10.1067/mjd.2001.113471
PMID:11312437
Abstract

Skin and nail changes from long-term hydroxyurea therapy are reported in adults. Skin and nail changes, including nail hyperpigmentation, longitudinal bands, and hyperpigmentation of the palms and other skin surfaces, developed in 7 children with sickle cell anemia after 6 to 16 weeks of hydroxyurea therapy. Cutaneous and nail changes may occur in children receiving hydroxyurea.

摘要

据报道,长期使用羟基脲治疗会导致成人皮肤和指甲出现变化。7名镰状细胞贫血患儿在接受羟基脲治疗6至16周后,出现了皮肤和指甲变化,包括指甲色素沉着、纵纹以及手掌和其他皮肤表面色素沉着。接受羟基脲治疗的儿童可能会出现皮肤和指甲变化。

相似文献

1
Skin and nail changes in children with sickle cell anemia receiving hydroxyurea therapy.接受羟基脲治疗的镰状细胞贫血患儿的皮肤和指甲变化。
J Am Acad Dermatol. 2001 May;44(5):859-61. doi: 10.1067/mjd.2001.113471.
2
Hydroxyurea therapy associated with declining serum levels of magnesium in children with sickle cell anemia.羟基脲疗法与镰状细胞贫血患儿血清镁水平下降有关。
J Pediatr. 2002 May;140(5):565-9. doi: 10.1067/mpd.2002.122644.
3
Hydroxyurea in very young children with sickle cell anemia is not a cure-all.羟基脲对镰状细胞贫血的幼儿并非万灵药。
J Pediatr. 2001 Dec;139(6):763-4. doi: 10.1067/mpd.2001.120093.
4
Cutaneous adverse reactions to hydroxyurea in patients with sickle cell disease.镰状细胞病患者对羟基脲的皮肤不良反应。
Arch Dermatol. 2001 Apr;137(4):467-70.
5
Hydroxyurea for sickle cell anemia.羟基脲用于镰状细胞贫血。
N Engl J Med. 2008 Jul 3;359(1):98; author reply 98-9.
6
Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.中间型地中海贫血患者对羟基脲的皮肤不良反应
Pediatr Dermatol. 2004 Nov-Dec;21(6):633-5. doi: 10.1111/j.0736-8046.2004.21603.x.
7
Hydroxyurea for the treatment of sickle cell anemia.羟基脲用于治疗镰状细胞贫血。
N Engl J Med. 2008 Mar 27;358(13):1362-9. doi: 10.1056/NEJMct0708272.
8
Hydroxyurea-induced splenic regrowth in an adult patient with severe hemoglobin SC disease.羟基脲诱导一名重度血红蛋白SC病成年患者的脾脏再生
Am J Hematol. 2003 Oct;74(2):125-6. doi: 10.1002/ajh.10388.
9
Are we underestimating the leukemogenic risk of hydroxyurea.我们是否低估了羟基脲的致白血病风险?
Saudi Med J. 2002 Nov;23(11):1411-3.
10
When should hydroxyurea be used for children with sickle cell disease?镰状细胞病患儿何时应使用羟基脲?
Pediatrics. 2008 Dec;122(6):1365-6. doi: 10.1542/peds.2008-1058.

引用本文的文献

1
Dermatomyositis-like Eruption Induced by Hydroxyurea-Case Report and Literature Review.羟基脲诱发的皮肌炎样皮疹——病例报告及文献综述
J Clin Med. 2025 Mar 23;14(7):2192. doi: 10.3390/jcm14072192.
2
Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.儿童和青少年镰状细胞病:撒哈拉以南非洲及其他地区的历史、临床和公共卫生视角综述
Int J Pediatr. 2022 Oct 8;2022:3885979. doi: 10.1155/2022/3885979. eCollection 2022.
3
Melanonychia.甲下黑素沉着
Dermatol Res Pract. 2012;2012:952186. doi: 10.1155/2012/952186. Epub 2012 Jun 27.
4
Genotype-phenotype relationship of patients with β-thalassemia taking hydroxyurea: a 13-year experience in Iran.β-地中海贫血患者服用羟基脲的基因型-表型关系:伊朗 13 年的经验。
Int J Hematol. 2012 Jan;95(1):51-6. doi: 10.1007/s12185-011-0985-6. Epub 2011 Dec 20.
5
How I use hydroxyurea to treat young patients with sickle cell anemia.我如何使用羟基脲治疗年轻的镰状细胞贫血患者。
Blood. 2010 Jul 1;115(26):5300-11. doi: 10.1182/blood-2009-04-146852. Epub 2010 Mar 11.
6
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.系统评价:羟基脲用于治疗成人镰状细胞病
Ann Intern Med. 2008 Jun 17;148(12):939-55. doi: 10.7326/0003-4819-148-12-200806170-00221. Epub 2008 May 5.